Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISAL 2019 | Critical care management of CAR-T related toxicities

New CAR T-cell treatments can ellicit immune-related adverse events, including cytokine release syndrome and neurotoxicity, which require critical care management. We spoke to Élie Azoulay, MD, PhD, of Hôpital Saint-Louis, Paris, France, at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany, about this important emerging area.